Metformin, pioglitazone, dapagliflozin and their combinations ameliorate manifestations associated with NAFLD in rats via anti-inflammatory, anti-fibrotic, anti-oxidant and anti-apoptotic mechanisms
Hager H. Shaaban, Ibrahim AlZaim, Ahmed El‐Mallah, Rania G. Aly, Ahmed F. El‐Yazbi, Ahmed Wahid
Topics & Concepts
MetforminPioglitazoneMedicineSteatosisInflammationMetabolic syndromeFatty liverNonalcoholic fatty liver diseaseInternal medicineInsulin resistanceOxidative stressLipotoxicityEndocrinologyDapagliflozinDyslipidemiaDiabetes mellitusPharmacologyInsulinType 2 Diabetes MellitusType 2 diabetesDiseaseLiver Disease Diagnosis and TreatmentDiet, Metabolism, and DiseaseMetabolism, Diabetes, and Cancer